Mercer Capital Advisers’s Celgene Corp CELG Stock Holding History

Mercer Capital Advisers’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,590	Closed	-$142K	–	242
2018 Q3	$142K	Sell	1,590 -100	-6%	-$8.84K	0.09%	104
2018 Q2	$134K	Hold	1,690	–	–	0.1%	108
2018 Q1	$151K	Hold	1,690	–	–	0.11%	103
2017 Q4	$176K	Hold	1,690	–	–	0.13%	98
2017 Q3	$246K	Hold	1,690	–	–	0.18%	83
2017 Q2	$219K	Hold	1,690	–	–	0.16%	87
2017 Q1	$210K	Sell	1,690 -210	-11%	-$25.1K	0.16%	87
2016 Q4	$220K	Hold	1,900	–	–	0.18%	86
2016 Q3	$199K	Buy	1,900 +1,250	+192%	+$135K	0.16%	90
2016 Q2	$64K	Hold	650	–	–	0.05%	144
2016 Q1	$65K	Hold	650	–	–	0.06%	136
2015 Q4	$78K	Hold	650	–	–	0.07%	126
2015 Q3	$70K	Hold	650	–	–	0.06%	129
2015 Q2	$75K	Hold	650	–	–	0.07%	140
2015 Q1	$75K	Hold	650	–	–	0.07%	140
2014 Q4	$73K	Buy	+650	New	+$68.6K	0.06%	138

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mercer Capital Advisers's CELG Position: Q4 2018 in Review

Mercer Capital Advisers sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 1,590 shares — an estimated $142K sold.

Mercer Capital Advisers first reported a position in CELG in Q4 2014 and held it in 16 quarters. The position peaked at $246K in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

Mercer Capital Advisers reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
Mercer Capital Advisers sold 1,590 Celgene Corp shares in Q4 2018, an estimated $142K.
Mercer Capital Advisers first reported a position in Celgene Corp in Q4 2014 and held it in 16 quarters.
Mercer Capital Advisers's Celgene Corp position peaked at $246K in Q3 2017.
1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Mercer Capital Advisers's 13F filing for Q4 2018, filed 17 Jan 2019.